by Eric Christianson | Aug 9, 2023 | Clinical Pharmacy News and New Drug Updates, Endocrine Medication and Disease State Clinical Pearls
There’s always this voice in the back of my head that always cautions me that all that glitters is not gold. After being heralded as the next savior in weight loss by the media, the GLP-1 Agonists/GIP agonists have come under more scrutiny lately in the news. A...
by Eric Christianson | Aug 6, 2023 | Renal, Urology, and Electrolytes Case Studies
Magnesium is an essential mineral used for many bodily functions. There are a few drugs that deplete magnesium and below is a case scenario where we have medications that should be ruled out as contributing factors. MW is a 67-year-old male with a history of...
by Eric Christianson | Aug 2, 2023 | Infectious Disease and Oncology Medication and Disease State Clinical Pearls
Clindamycin is an antibiotic that has been around for a long time. There are quite a few quirks with this medication and I wanted to cover my top 5 clindamycin clinical pearls that may show up on board exams and in clinical practice. C. Diff Risk Let’s start...
by Eric Christianson | Apr 12, 2023 | Endocrine Medication and Disease State Clinical Pearls
It is theorized that patients who are taking a GLP-1 agonist are at a greater risk for pancreatitis due to the medication causing an increase in stimulation of GLP-1 receptors located in the pancreas. This could lead to an overgrowth or overactivation of pancreatic...
by Eric Christianson | Apr 9, 2023 | Cardiovascular Medication and Disease State Clinical Pearls
Bempedoic acid, also known as Nexletol, is a once-daily medication used in patients with increased atherosclerotic cardiovascular disease (ASCVD) or heterozygous familial hypercholesterolemia who are requiring additional LDL-C lowering previously on a maximally...
